Your browser doesn't support javascript.
loading
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss.
Wharton, Sean; Calanna, Salvatore; Davies, Melanie; Dicker, Dror; Goldman, Bryan; Lingvay, Ildiko; Mosenzon, Ofri; Rubino, Domenica M; Thomsen, Mette; Wadden, Thomas A; Pedersen, Sue D.
Afiliação
  • Wharton S; York University, McMaster University and Wharton Weight Management Clinic, Toronto, Ontario, Canada.
  • Calanna S; Novo Nordisk A/S, Søborg, Denmark.
  • Davies M; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Dicker D; NIHR Leicester Biomedical Research Centre, Leicester, UK.
  • Goldman B; Internal Medicine Department & Obesity Clinic, Hasharon Hospital-Rabin Medical Center, Petach-Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Lingvay I; Novo Nordisk A/S, Søborg, Denmark.
  • Mosenzon O; Departments of Internal Medicine/Endocrinology and Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Rubino DM; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Thomsen M; Washington Center for Weight Management and Research, Arlington, Virginia, USA.
  • Wadden TA; Novo Nordisk A/S, Søborg, Denmark.
  • Pedersen SD; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Diabetes Obes Metab ; 24(1): 94-105, 2022 01.
Article em En | MEDLINE | ID: mdl-34514682
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Sobrepeso Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Sobrepeso Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article